Onconova Therapeutics, Inc. to Provide Corporate Update and Second Quarter 2019 Financial Results
August 07, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
Conference Call and Webcast at 9 a.m. Eastern Time on August 14, 2019 NEWTOWN, Pa., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical...
Onconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology Association
June 10, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., June 10, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics Announces Presentations at Three Upcoming Conferences
May 28, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 28, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics Announces License Agreement with HanX Biopharmaceuticals to Develop and Commercialize Rigosertib in Greater China
May 13, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
Onconova to Receive $4 Million Upfront, including $2 Million Fee and $2 Million for Onconova Shares Purchased at a Premium, Plus up to $45.5 Million in Regulatory and Sales Milestones for Rigosertib...
Onconova Therapeutics, Inc. to Provide Corporate Update and First Quarter 2019 Financial Results
May 07, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 07, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug...
Onconova Therapeutics Announces Presentations at the 15th International Symposium on Myelodysplastic Syndromes (MDS 2019) in Copenhagen, Denmark
May 06, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., May 06, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug...
Onconova Therapeutics to Present Update at the 2019 HCW Global Life Sciences Conference in London, April 7-9
April 02, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Achieves Over 75 Percent of Planned Enrollment in Pivotal Phase 3 INSPIRE Study of Rigosertib in Myelodysplastic Syndromes
March 25, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
Full enrollment of 360 patients anticipated in second half of 2019Pivotal global study continues enrolling worldwide Potential for first new therapy in 15 years to address unmet medical need in MDS ...
Onconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2018 Financial Results
March 19, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., March 19, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics, Inc. to Participate at the 31st Annual ROTH Conference March 17-19, 2019 in Orange County, CA
March 12, 2019 07:30 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., March 12, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat...